Data from clinical trials aimed at evaluating the efficacy of combination therapy with metformin/pioglitazone/exenatide versus sequential addition of metformin followed by glipizide and insulin in patients with long-standing type 2 diabetes mellitus (T2DM) have recently been recently published. This evidence concerns the gene INS and diabetes mellitus.